The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor α activities in normal equine joints

Equine Veterinary Journal

Volumn 36, Issue 2, 2004, Pages 155-159

  Van Den Boom, R ^a   Brama, P A J ^a   Kiers, G H ^b   DeGroot, J ^b   Barneveld, A ^a   Van Weeren, P R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Arthrocentesis; Exercise; Horse; MMPs; TNF

Indexed keywords

BIOLOGICAL MARKER; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTHROCENTESIS; ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; JOINT; MALE; METACARPOPHALANGEAL JOINT; NONHUMAN; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

EQUIDAE; EQUUS CABALLUS;

EID: 2542549756     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/0425164044868602     Document Type: Article

References (38)

1. Bertone, A.L., Palmer, J.L. and Jones, J. (2001) Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet. Surg. 30, 528-538.
2. Billinghurst, R.C., Fretz, P.B. and Gordon, J.R. (1995) Induction of intra-articular tumour necrosis factor during acute inflammatory responses in equine arthritis. Equine vet. J. 27, 208-216.
3. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J.A. (1993) Matrix metalloproteinases: a review. Crit Rev. oral Biol. Med. 4, 197-250.
4. Bluteau, G., Conrozier, T., Mathieu P., Vignon, E., Herbage, D. and Mallein-Gerin, F. (2001) Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim. Biophys. Acta 1526, 147-158.
5. Brama, P.A., TeKoppele, J.M., Beekman, B., van Weeren, P.R. and Barneveld, A. (1998) Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis and osteochondrosis. Ann. Rheum. Dis. 57, 697-699.
6. Chambers, M.G., Cox, L., Chong, L., Suri, N., Cover, P., Bayliss, M.T. and Mason, R.M. (2001) Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. Arthritis Rheum. 44, 1455-1465.
7. Chubinskaya, S., Kuettner, K.E. and Cole, A.A. (1999) Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab. Invest. 79, 1669-1677.
8. Clegg, P.D., Coughlan, A.R., Riggs, C.M. and Carter, S.D. (1997a) Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine vet. J. 29, 343-348.
9. Clegg, P.D., Burke, R.M., Coughlan, A.R., Riggs, C.M. and Carter, S.D. (1997b) Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Equine vet. J. 29, 335-342.
10. Conway, J.G. Andrews, R.C., Beaudet, B., Bickett, D.M., Boncek, V., Brodie, T.A., Clark, R.L., Crumrine, R.C., Leenitzer, M.A., McDougald, D.L., Han, B., Hedeen, K., Lin, P., Milla, M., Moss, M., Pink, H., Rabinowitz, M.H., Tippin, T., Scates, P.W., Selph, J., Stimpson, S.A., Warner, J. and Becherer, J.D. (2001) Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. J. Pharmacol. expt. Ther. 298, 900-908.
11. DeGroot, J., Verzijl, N., Wenting-Van Wijk, M.J., Bank, R.A., Lafeber, F.P., Bijlsma, J.W. and TeKoppele, J.M. (2001) Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum. 44, 2562-2571.
12. Eskandari, M.K., Nguyen, D.T., Kunkel, S.L. and Remick, D.G. (1990) WEHI 164 subclone 13 assay for TNF: sensitivity, specificity and reliability. Immunol. Invest. 19, 69-79.
13. Haapala, J., Arokoski, J.P., Ronkko, S., Agren, U., Kosma, V.M., Lohmander, L.S., Tammi, M., Helminen, H.J. and Kiviranta, I. (2001) Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP and chondroitin sulphate levels in young beagle dogs. Ann. Rheum. Dis. 60, 55-60.
14. Hawkins, D.L., Cargile, J.L., MacKay, R.J., Broome, T.A. and Skelley, L.A. (1995) Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Am. J. vet. Res. 56, 1292-1299.
15. Hembry, R.M., Bagga, M.R., Reynolds, J.J. and Hamblen, D.L. (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann. Rheum. Dis. 54, 25-32.
16. Jouglin, M., Robert, C., Valette, J.P., Gavard, F., Quintin-Colonna, F. and Denoix, J.M. (2000) Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Vet. Res. 31, 507-515.
17. Kidd, J.A., Fuller, C. and Barr, A.R.S. (2001) Osteoarthritis in the horse. Equine vet. Educ. 13, 160-168.
18. Lohmander, L.S., Hoerrner, L.A. and Lark, M.W. (1993) Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 36, 181-189.
19. Lohmander, L.S., Lark, M.W., Dahlberg, L., Walakovits, L.A. and Roos, H. (1992) Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum and urine. Clin. Biochem. 25, 167-174.
20. Lohmander, L.S., Roos, H., Dahlberg, L., Hoerrner, L.A. and Lark, M.W. (1994) Temporal patterns of stromelysin-1, tissue inhibitor and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. J. Orthop. Res. 12, 21-28.
21. Lohmander, L.S., Dahlberg, L., Eyre, D., Lark, M., Thonar, EJ. and Ryd, L. (1998) Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities. Osteoarthritis Cartilage 6, 351-361.
22. Manicourt, D.H., Fujimoto N., Obata, K. and Thonar, E.J. (1994) Serum levels of collagenase, stromelysin-1 and TIMP-1. Age- and sex- related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum. 37, 1774-1783.
23. Murphy, G. and Knauper, V. (1997) Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 15, 511-518.
24. Murphy, G., Hembry, R.M., Hughes, C.E., Fosang, A.J. and Hardingham, T.E. (1990) Role and regulation of metalloproteinases in connective tissue turnover. Biochem. Soc. Trans. 18, 812-815.
25. Olivier, A., Nurton, J.P. and Guthrie, A.J. (1997) An epizoological study of wastage in thoroughbred racehorses in Gauteng, South Africa. J. S. Afr. vet. Ass. 68, 125-129.
26. Panula, H.E., Lohmander, L.S., Ronkko, S., Agren, U., Helminen, H.J. and Kiviranta, I. (1998) Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs. Acta Orthop. Scand. 69, 152-158.
27. Pap, G., Eberhardt, R., Sturmer, I., Machner, A., Schwarzberg, H., Roessner, A. and Neumann, W. (1998) Development of osteoarthritis in the knee joints of Wistar rats after strenuous running exercise in a running wheel by intracranial self-stimulation. Path. Res. Pract. 194, 41-47.
28. Pool, R.R. (1996) Pathologic manifestations of joint disease in the athletic horse. In: Joint Disease in the Horse, Eds: C.W. McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia. pp 87-104.
29. Richardson, D.W. and Dodge, G.R. (2000) Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes. Am. J. vet. Res. 61, 624-630.
30. Roos, H., Dahlberg, L., Hoerrner, L.A., Lark, M.W., Thonar, E.J., Shinmei, M., Lindqvist, U. and Lohmander, L.S. (1995) Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage 3, 7-14.
31. Rossdale, P.D., Hopes, R., Wingfield Digby, N.J. and Offord, K. (1985) Epidemiological study of wastage among racehorses 1982 and 1983. Vet. Rec. 116, 66-69.
32. Spiers, S., May, S.A., Bennett, D. and Edwards, G.B. (1994) Cellular sources of proteolytic enzymes in equine joints. Equine vet. J. 26, 43-47.
33. Todhunter, R.J. (1992) Synovial joint anatomy, biology and pathobiology. In: Equine Surgery, Ed: J.A. Auer, W.B. Saunders Co., Philadelphia. pp 844-866.
34. Todhunter, R.J. and Lust, G. (1990) Pathophysiology of synovitis: Clinical signs and examination in horses. Comp. cont. Educ. pract. Vet. 12, 980-992.
35. Todhunter, R.J., Fubini, S.L., Freeman, K.P. and Lust, G. (1997) Concentrations of keratan sulfate in plasma and synovial fluid from clinically normal horses and horses with joint disease. J. Am. vet. med. Ass. 210, 369-374.
36. Trotter, G.W. and McIlwraith, C.W. (1996) Clinical features and diagnosis of equine joint disease. In: Joint Disease in the Horse, Eds: C.W. McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia, pp 120-145.
37. Trumble, T.N., Trotter, G.W., Oxford, J.R., McIlwraith, C.W., Cammarata, S., Goodnight, J.L., Billinghurst, R.C. and Frisbie, D.D. (2001) Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am. J. vet. Res. 62, 1467-1477.
38. Viitanen, M., Bird, J., Maisi, P., Smith, R., Tulamo, R.M. and May, S. (2000) Differences in the concentration of various synovial fluid constituents between the distal interphalangeal joint, the metacarpophalangeal joint and the navicular bursa in normal horses. Res. vet. Sci. 69, 63-67.